NI Reports Record Orders for a First Quarter
Company Continues to Deliver Operating Leverage With Non-GAAP Operating Income up 16% YOY
Q1 2014 Highlights
- Quarterly revenue of $285 million, down 1% YOY
- Record orders for a first quarter
- Fully diluted GAAP EPS of $0.15 and fully diluted non-GAAP EPS of $0.21
- EBITDA of $41 million or $0.32 per share
- Record cash and cash equivalents of $410 million
AUSTIN, Texas, April 29, 2014 /PRNewswire/ -- National Instruments (Nasdaq: NATI) today announced Q1 revenue of $285 million, down 1 percent year-over-year. Backlog increased by $7.5 million and deferred revenue increased by $6 million in the first quarter. The company's orders under $20,000 grew 4 percent year-over-year; orders between $20,000 and $100,000 increased 5 percent year-over-year; and orders above $100,000 decreased 10 percent year-over-year. In Q1 2014, NI recognized $7 million in revenue from its largest customer, compared with approximately $4 million recognized in Q1 2013.
GAAP net income for Q1 was $19 million, with fully diluted earnings per share (EPS) of $0.15, and non-GAAP net income was $26 million, with non-GAAP fully diluted EPS of $0.21. EBITDA, or Earnings Before Interest, Taxes, Depreciation and Amortization, was $41 million, or $0.32 per share for Q1.
In Q1, GAAP gross margin was 75 percent and non-GAAP gross margin was 76 percent, up 30 basis points from Q4 2013. Total GAAP operating expenses were up 2 percent sequentially and were down 4 percent year-over-year. Total non-GAAP operating expenses were $182 million, up 3 percent sequentially and down 4 percent year-over-year.
GAAP operating margin was 8 percent in Q1, with GAAP operating income of $24 million, up 23 percent year-over-year. Non-GAAP operating margin was 12 percent in Q1, with non-GAAP operating income of $34 million, up 16 percent year-over-year.
The company's non-GAAP results exclude the impact of stock-based compensation, amortization of acquisition-related intangibles, acquisition-related adjustments and acquisition-related transaction costs. Reconciliations of the company's GAAP and non-GAAP results are included as part of this news release.
"Although Q1 remained challenging, we received record orders for a first quarter, which indicates continued strong interest from customers in our software-based modular platform," said Dr. James Truchard, NI president, CEO and co-founder. "We remained focused on spending discipline as well as leveraging our investments to further our platform offering so customers can continue to solve the toughest engineering challenges."
Geographic revenue in U.S. dollar terms for Q1 2014 compared to Q1 2013 was down 4 percent in the Americas, up 6 percent in Europe, up 1 percent in East Asia and down 10 percent in Emerging Markets. In local currency terms, revenue was up 4 percent in Europe, up 3 percent in East Asia and flat in Emerging Markets.
As of March 31, NI had a record $410 million in cash and short-term investments, up $17 million from Dec. 31, 2013. The company paid $19 million in dividends in the first quarter. The NI Board of Directors also approved a quarterly dividend of $0.15 per share on the company's common stock payable on June 2 to stockholders of record on May 12.
Guidance for Q2 2014
"We believe our ability to continue to gain market share in a challenging environment continues to validate our disruptive approach," said Alex Davern, NI COO and CFO. "Improvement in the Global PMI over the last six months gives us increased confidence in the continued recovery of the industrial economy. This confidence combined with our continued commitment to deliver on our leverage plan leads us to expect improved operating margins in Q2."
NI currently expects revenue for Q2 2014 to be between $296 million and $324 million. NI expects fully diluted EPS to be in the range of $0.13 to $0.25 for Q2, with non-GAAP fully diluted EPS expected to be in the range of $0.19 to $0.31.
Non-GAAP Presentation
In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this news release, the company has presented its gross profit, gross margin, operating expenses, operating income, operating margin, income before income taxes, provision for income taxes, net income and basic and fully diluted EPS for the three-month periods ending March 31, 2014 and 2013, on a GAAP and non-GAAP basis. NI is also providing guidance on its non-GAAP operating margin and fully diluted EPS.
When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company's operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider stock-based compensation expense, amortization of acquisition-related intangibles, acquisition-related adjustments and acquisition-related transaction costs in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods, to establish operational goals, to compare with its business plan and individual operating budgets, to measure management performance for the purposes of executive compensation including payments to be made under bonus plans, to assist the public in measuring the company's performance relative to the company's long-term public performance goals, to allocate resources and, relative to the company's historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance.
This news release also discloses the company's EBITDA and EBITDA diluted EPS for the three-month periods ending March 31, 2014 and 2013. The company also believes that including the EBITDA results assists investors in assessing the company's operational performance relative to its competitors. A reconciliation of EBITDA and EBITDA diluted EPS to GAAP net income and GAAP diluted EPS is included with this news release.
Conference Call Information and Availability of Presentation Materials
Interested parties can listen to the Q1 2014 conference call today, April 29, at 4:00 p.m. CT at ni.com/call. Replay information is available by calling (855) 859-2056, confirmation code #20262052, shortly after the call through May 4 at 11:00 p.m. CT, or by visiting the company's website at ni.com/call. You may also view certain presentation materials that we may refer to on the conference call at ni.com/nati.
Forward-Looking Statements
This release contains "forward-looking statements," including statements regarding furthering our platform offering so customers can continue to solve the toughest engineering challenges, continuing to gain market share in a challenging environment continues to validate our disruptive approach, increased confidence in the continued recovery, expecting improved operating margins in Q2 and NI's Q2 guidance for revenue and GAAP and non-GAAP EPS. These statements are subject to a number of risks and uncertainties, including the risk of adverse changes or fluctuations in the global economy, foreign exchange fluctuations, component shortages, delays in the release of new products, fluctuations in customer demand for NI products including orders from NI's largest customer, fluctuations in average order size and customer mix, the company's ability to effectively manage its operating expenses, manufacturing inefficiencies and the level of capacity utilization, and the impact of any acquisitions by NI. Actual results may differ materially from the expected results.
The company directs readers to its Form 10-K for the fiscal year ended Dec. 31, 2013, and the other documents it files with the SEC for other risks associated with the company's future performance.
About NI
Since 1976, NI (www.ni.com) has equipped engineers and scientists with tools that accelerate productivity, innovation and discovery. NI's graphical system design approach to engineering provides an integrated software and hardware platform that speeds the development of any system needing measurement and control. The company's long-term vision and focus on improving society through its technology supports the success of its customers, employees, suppliers and shareholders. Readers can obtain investment information from the company's investor relations department by calling (512) 683-5090, emailing [email protected] or visiting www.ni.com/nati. (NATI-F)
National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.
Contact: Marissa Vidaurri, Investor Relations, [email protected]
National Instruments |
||||
Condensed Consolidated Balance Sheets |
||||
(in thousands) |
||||
March 31, |
December 31, |
|||
2014 |
2013 |
|||
(unaudited) |
||||
Assets |
||||
Current assets: |
||||
Cash and cash equivalents |
$ |
240,701 |
$ |
230,263 |
Short-term investments |
169,409 |
163,149 |
||
Accounts receivable, net |
181,545 |
180,680 |
||
Inventories, net |
170,257 |
172,109 |
||
Prepaid expenses and other current assets |
51,723 |
49,001 |
||
Deferred income taxes, net |
35,324 |
33,393 |
||
Total current assets |
848,959 |
828,595 |
||
Property and equipment, net |
262,518 |
260,568 |
||
Goodwill |
146,544 |
146,520 |
||
Intangible assets, net |
83,484 |
82,310 |
||
Other long-term assets |
24,173 |
25,558 |
||
Total assets |
$ |
1,365,678 |
$ |
1,343,551 |
Liabilities and Stockholders' Equity |
||||
Current liabilities: |
||||
Accounts payable |
$ |
62,827 |
$ |
56,614 |
Accrued compensation |
21,817 |
25,189 |
||
Deferred revenue – current |
102,155 |
96,117 |
||
Accrued expenses and other liabilities |
16,567 |
17,627 |
||
Other taxes payable |
29,752 |
29,808 |
||
Total current liabilities |
233,118 |
225,355 |
||
Deferred income taxes |
43,294 |
44,620 |
||
Liability for uncertain tax positions |
24,145 |
23,572 |
||
Deferred revenue – long-term |
21,261 |
21,389 |
||
Other long-term liabilities |
6,119 |
5,531 |
||
Total liabilities |
327,937 |
320,467 |
||
Stockholders' equity: |
||||
Preferred stock |
- |
- |
||
Common stock |
1,261 |
1,257 |
||
Additional paid-in capital |
621,211 |
604,330 |
||
Retained earnings |
414,765 |
414,947 |
||
Accumulated other comprehensive income |
504 |
2,550 |
||
Total stockholders' equity |
1,037,741 |
1,023,084 |
||
Total liabilities and stockholders' equity |
$ |
1,365,678 |
$ |
1,343,551 |
National Instruments |
||||
Condensed Consolidated Statements of Income |
||||
(in thousands, except per share data) |
||||
Three Months Ended |
||||
March 31, |
||||
(unaudited) |
||||
2014 |
2013 |
|||
Net sales: |
||||
Product |
$ |
262,264 |
$ |
265,418 |
Software maintenance |
22,410 |
21,070 |
||
Total net sales |
284,674 |
286,488 |
||
Cost of sales: |
||||
Product |
69,621 |
68,626 |
||
Software maintenance |
1,581 |
1,614 |
||
Total cost of sales |
71,202 |
70,240 |
||
Gross profit |
213,472 |
216,248 |
||
Operating expenses: |
||||
Sales and marketing |
111,916 |
114,070 |
||
Research and development |
55,259 |
61,256 |
||
General and administrative |
22,473 |
22,844 |
||
Acquisition-related adjustment |
- |
(1,316) |
||
Total operating expenses |
189,648 |
196,854 |
||
Operating income |
23,824 |
19,394 |
||
Other income (expense): |
||||
Interest income |
197 |
185 |
||
Net foreign exchange gain (loss) |
50 |
(1,462) |
||
Other income, net |
88 |
24 |
||
Income before income taxes |
24,159 |
18,141 |
||
Provision for (benefit from) income taxes |
5,436 |
(459) |
||
Net income |
$ |
18,723 |
$ |
18,600 |
Basic earnings per share |
$ |
0.15 |
$ |
0.15 |
Diluted earnings per share |
$ |
0.15 |
$ |
0.15 |
Weighted average shares outstanding – |
||||
Basic |
125,973 |
123,306 |
||
Diluted |
126,725 |
124,365 |
||
Dividends declared per share |
$ |
0.15 |
$ |
0.14 |
National Instruments |
||||
Condensed Consolidated Statements of Cash Flows |
||||
(in thousands) |
||||
Three Months Ended |
||||
March 31, |
||||
(unaudited) |
||||
2014 |
2013 |
|||
Cash flow from operating activities: |
||||
Net income |
$ |
18,723 |
$ |
18,600 |
Adjustments to reconcile net income to net cash provided |
||||
by operating activities: |
||||
Depreciation and amortization |
16,994 |
16,829 |
||
Stock-based compensation |
6,553 |
7,134 |
||
Tax benefit from deferred income taxes |
(3,198) |
(1,902) |
||
Tax benefit from stock option plans |
(70) |
(459) |
||
Changes in operating assets and liabilities: |
||||
Accounts receivable |
(865) |
15,115 |
||
Inventories |
1,852 |
(18,045) |
||
Prepaid expenses and other assets |
(2,790) |
(12,969) |
||
Accounts payable |
6,213 |
1,603 |
||
Deferred revenue |
5,910 |
3,776 |
||
Taxes and other liabilities |
(3,180) |
(9,200) |
||
Net cash provided by operating activities |
46,142 |
20,482 |
||
Cash flow from investing activities: |
||||
Capital expenditures |
(11,959) |
(19,094) |
||
Capitalization of internally developed software |
(7,602) |
(2,803) |
||
Additions to other intangibles |
(1,049) |
(1,418) |
||
Purchases of short-term investments |
(9,649) |
(8,177) |
||
Sales and maturities of short-term investments |
3,389 |
26,092 |
||
Net cash used by investing activities |
(26,870) |
(5,400) |
||
Cash flow from financing activities: |
||||
Proceeds from issuance of common stock |
10,000 |
11,798 |
||
Dividends paid |
(18,904) |
(17,281) |
||
Tax benefit from stock option plans |
70 |
459 |
||
Net cash used by financing activities |
(8,834) |
(5,024) |
||
Net change in cash and cash equivalents |
10,438 |
10,058 |
||
Cash and cash equivalents at beginning of period |
230,263 |
161,996 |
||
Cash and cash equivalents at end of period |
$ |
240,701 |
$ |
172,054 |
National Instruments |
||||
Detail of GAAP Charges Related to Stock-Based Compensation, Amortization of Acquisition Intangibles |
||||
(unaudited) |
||||
Three Months Ended |
||||
March 31, |
||||
2014 |
2013 |
|||
Stock-based compensation |
||||
Cost of sales |
$ |
441 |
$ |
421 |
Sales and marketing |
2,811 |
3,073 |
||
Research and development |
2,451 |
2,737 |
||
General and administrative |
850 |
903 |
||
Provision for income taxes |
(1,836) |
(1,814) |
||
Total |
$ |
4,717 |
$ |
5,320 |
Amortization of acquisition intangibles |
||||
Cost of sales |
$ |
2,666 |
$ |
2,760 |
Sales and marketing |
466 |
518 |
||
Research and development |
406 |
673 |
||
Other income, net |
170 |
193 |
||
Provision for income taxes |
(1,224) |
(1,350) |
||
Total |
$ |
2,484 |
$ |
2,794 |
Acquisition-related adjustment and transaction costs |
||||
Sales and marketing |
$ |
88 |
$ |
118 |
Research and development |
153 |
144 |
||
General and administrative |
65 |
106 |
||
Acquisition-related adjustment |
- |
(1,316) |
||
Provision for income taxes |
(107) |
(106) |
||
Total |
$ |
199 |
$ |
(1,054) |
National Instruments |
||||
Reconciliation of GAAP to Non-GAAP Measures |
||||
(in thousands, except per share data) |
||||
(unaudited) |
||||
Three Months Ended |
||||
March 31, |
||||
2014 |
2013 |
|||
Reconciliation of Gross Profit to Non-GAAP Gross Profit |
||||
Gross profit, as reported |
$ |
213,472 |
$ |
216,248 |
Stock-based compensation |
441 |
421 |
||
Amortization of acquisition intangibles |
2,666 |
2,760 |
||
Acquisition-related transaction costs |
- |
- |
||
Non-GAAP gross profit |
$ |
216,579 |
$ |
219,429 |
Non-GAAP gross margin |
76% |
77% |
||
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses |
||||
Operating expenses, as reported |
$ |
189,648 |
$ |
196,854 |
Stock-based compensation |
(6,112) |
(6,713) |
||
Amortization of acquisition intangibles |
(872) |
(1,191) |
||
Acquisition-related adjustment |
- |
1,316 |
||
Acquisition-related transaction costs |
(306) |
(368) |
||
Non-GAAP operating expenses |
$ |
182,358 |
$ |
189,898 |
Reconciliation of Operating Income to Non-GAAP Operating Income |
||||
Operating income, as reported |
$ |
23,824 |
$ |
19,394 |
Stock-based compensation |
6,553 |
7,134 |
||
Amortization of acquisition intangibles |
3,538 |
3,951 |
||
Acquisition-related adjustment |
- |
(1,316) |
||
Acquisition-related transaction costs |
306 |
368 |
||
Non-GAAP operating income |
$ |
34,221 |
$ |
29,531 |
Non-GAAP operating margin |
12% |
10% |
||
Reconciliation of Income Before Income Taxes to Non-GAAP Income Before Income Taxes |
||||
Income before income taxes, as reported |
$ |
24,159 |
$ |
18,141 |
Stock-based compensation |
6,553 |
7,134 |
||
Amortization of acquisition intangibles |
3,708 |
4,144 |
||
Acquisition-related adjustment |
- |
(1,316) |
||
Acquisition-related transaction costs |
306 |
368 |
||
Non-GAAP income before income taxes |
$ |
34,726 |
$ |
28,471 |
Reconciliation of Provision for Income Taxes to Non-GAAP Provision for Income Taxes |
||||
Provision for income taxes, as reported |
$ |
5,436 |
$ |
(459) |
Stock-based compensation |
1,836 |
1,814 |
||
Amortization of acquisition intangibles |
1,224 |
1,350 |
||
Acquisition-related adjustment and transaction costs |
107 |
106 |
||
Non-GAAP provision for income taxes |
$ |
8,603 |
$ |
2,811 |
National Instruments |
||||
Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to Non-GAAP Net Income, Non-GAAP Basic EPS and Non-GAAP Diluted EPS |
||||
(unaudited) |
||||
Three Months Ended |
||||
March 31, |
||||
2014 |
2013 |
|||
Net income, as reported |
$ |
18,723 |
$ |
18,600 |
Adjustments to reconcile net income to non-GAAP net income: |
||||
Stock-based compensation, net of tax effect |
4,717 |
5,320 |
||
Amortization of acquisition intangibles, net of tax effect |
2,484 |
2,794 |
||
Acquisition-related adjustment |
- |
(1,316) |
||
Acquisition-related transaction costs, net of tax effect |
199 |
262 |
||
Non-GAAP net income |
$ |
26,123 |
$ |
25,660 |
Basic EPS, as reported |
$ |
0.15 |
$ |
0.15 |
Adjustment to reconcile basic EPS to non-GAAP |
||||
basic EPS: |
||||
Impact of stock-based compensation, net of tax effect |
$ |
0.04 |
$ |
0.05 |
Impact of amortization of acquisition intangibles, net of tax effect |
0.02 |
0.02 |
||
Acquisition-related adjustment |
- |
(0.01) |
||
Acquisition-related transaction costs, net of tax effect |
- |
- |
||
Non-GAAP basic EPS |
$ |
0.21 |
$ |
0.21 |
Diluted EPS, as reported |
$ |
0.15 |
$ |
0.15 |
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS |
||||
Impact of stock-based compensation, net of tax effect |
$ |
0.04 |
$ |
0.05 |
Impact of amortization of acquisition intangibles, net of tax effect |
0.02 |
0.02 |
||
Acquisition-related adjustment |
- |
(0.01) |
||
Acquisition-related transaction costs, net of tax effect |
- |
- |
||
Non-GAAP diluted EPS |
$ |
0.21 |
$ |
0.21 |
Weighted average shares outstanding – |
||||
Basic |
125,973 |
123,306 |
||
Diluted |
126,725 |
124,365 |
National Instruments |
||||
Reconciliation of Net Income and Diluted EPS to EBITDA and EBITDA Diluted EPS |
||||
(unaudited) |
||||
Three Months Ended |
||||
March 31, |
||||
2014 |
2013 |
|||
Net income, as reported |
$ |
18,723 |
$ |
18,600 |
Adjustments to reconcile net income to EBITDA – |
||||
Interest income |
(197) |
(185) |
||
Tax expense |
5,436 |
(459) |
||
Depreciation and amortization |
16,994 |
16,829 |
||
EBITDA |
$ |
40,956 |
$ |
34,785 |
Diluted EPS, as reported |
$ |
0.15 |
$ |
0.15 |
Adjustment to reconcile diluted EPS to EBITDA |
||||
Interest income |
- |
- |
||
Taxes |
0.04 |
- |
||
Depreciation and amortization |
0.13 |
0.13 |
||
EBITDA diluted EPS |
$ |
0.32 |
$ |
0.28 |
Weighted average shares outstanding – Diluted |
126,725 |
124,365 |
||
Reconciliation of GAAP to Non-GAAP EPS Guidance |
||||
(unaudited) |
||||
Three Months Ended |
||||
June 30, 2014 |
||||
Low |
High |
|||
GAAP Fully Diluted EPS, guidance |
$ |
0.13 |
$ |
0.25 |
Adjustment to reconcile diluted EPS to non-GAAP |
||||
diluted EPS: |
||||
Impact of stock-based compensation, net of tax effect |
0.04 |
0.04 |
||
Impact of amortization of acquisition intangibles, net of tax effect |
0.02 |
0.02 |
||
Non-GAAP diluted EPS, guidance |
$ |
0.19 |
$ |
0.31 |
SOURCE National Instruments
Share this article